McKenzie Paul
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to McKenzie Paul. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| BIIB | EVP Pharmaceutical Oper & Tech | Tax Withholding | 253 | $334.10 | $84,527 | Mar 1, 2019 |
| BIIB | EVP Pharmaceutical Oper & Tech | Tax Withholding | 643 | $332.87 | $214,035 | Feb 15, 2019 |
| BIIB | EVP Pharmaceutical Oper & Tech | Option Exercise | 1,263 | — | — | Feb 12, 2019 |
| BIIB | EVP Pharmaceutical Oper & Tech | Tax Withholding | 237 | $282.35 | $66,917 | Mar 1, 2018 |
| BIIB | EVP Pharmaceutical Oper & Tech | Tax Withholding | 442 | $299.38 | $132,326 | Feb 15, 2018 |
| BIIB | EVP Pharmaceutical Oper & Tech | Option Exercise | 481 | — | — | Mar 1, 2017 |